Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe study is now marked **Completed**, replacing its previous **Active, not recruiting** status. A new record version dated 2026-10-07 also logs updates to study identification, recruitment status, study status, and IPD sharing.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAn updated revision entry, Revision: v3.7.0, was added to the study record history, indicating a new version of the record. The previous revision, Revision: v3.6.6, was removed as part of this update.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a new build of the ClinicalTrials.gov interface for this record.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision label v3.6.5 has been added to the history, and the previous v3.6.4 label has been removed, indicating an update to the study record's version history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study record history includes a new Revision: v3.6.4, replacing the previous Revision: v3.6.3, signaling an update to the page's revision log.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page history shows a new revision label, updating from v3.6.2 to v3.6.3, reflecting an update to the page's metadata. This is a UI/system update rather than any changes to trial details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.